[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
aponia_analytics @AponiaAnalytics on x 5020 followers
Created: 2025-07-27 16:16:31 UTC
🦉 XX mg tirzepatide achieved −20.9% weight loss (−17.8% placebo-subtracted) at XX weeks in SURMOUNT-1; XX% of SELECT trial participants were nonresponders to semaglutide.
#GLP1 #obesity $NVO $LLY $AZN $SNY $GSK $PFE $RHHBY $ZLDPF $VKTX $VANI $HIMS
XXX engagements
